Filter
1005
Text search:
therapeutic
agents
Featured
Recommendations
129
New Publications
267
Language
Document type
No document type
521
Guidelines
217
Studies & Reports
159
Manuals
52
Strategic & Response Plan
19
Training Material
14
Fact sheets
10
Situation Updates
8
Brochures
2
Resource Platforms
1
Infographics
1
Online Courses
1
Countries / Regions
India
75
South Africa
41
Kenya
35
Global
33
Ethiopia
27
Uganda
21
Nigeria
20
Zambia
17
Tanzania
16
Latin America and the Carribbean
16
Sierra Leone
14
Bangladesh
14
Liberia
13
Nepal
13
Ghana
12
Rwanda
12
Western and Central Europe
12
Myanmar / Burma
10
Philippines
8
Congo, Democratic Republic of
7
Namibia
7
Cambodia
6
Lesotho
6
Africa
6
Russia
6
Burkina Faso
5
USA
5
Zimbabwe
5
Guinea
4
Thailand
4
Indonesia
4
Malawi
4
Mozambique
4
Brazil
4
Ukraine
4
Senegal
3
Mali
3
Cameroon
3
Haiti
3
Germany
3
Syria
3
Eswatini/ Swaziland
3
North Macedonia
3
Spain
3
South Sudan
2
Iraq
2
Afghanistan
2
Sudan
2
Benin
2
Botswana
2
Yemen
2
Middle East and North Africa
2
South–East Asia Region
2
Asia
2
Fiji
2
Bhutan
2
Venezuela
2
Tajikistan
2
Georgia
2
Vietnam
2
Gabon
2
Somalia
1
Pakistan
1
Jordan
1
Turkey
1
China
1
Malaysia
1
Singapore
1
Peru
1
Serbia
1
Colombia
1
Libya
1
Angola
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Paraguay
1
Solomon Islands
1
Eastern Europe
1
Albania
1
Armenia
1
Laos
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
North America
1
Denmark
1
France
1
Maldives
1
Mauritius
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
391
Clinical Guidelines
152
Public Health
49
Women & Child Health
42
Key Resources
28
Pharmacy & Technologies
16
Capacity Building
12
Toolboxes
AMR
149
Mental Health
74
Pharmacy
70
HIV
57
TB
53
COVID-19
44
Ebola
35
NCDs
33
NTDs
30
Caregiver
29
Rapid Response
24
Disability
10
Refugee
10
Planetary Health
10
Conflict
8
Natural Hazards
7
Specific Hazards
5
Cholera
3
Polio
2
Zika
2
Global Health Education
2
Social Ethics
2
Health Financing Toolbox
1
It is Zika virus (ZIKV) that most often causes these neurological effects it appears to be the only arbovirus than can cause congenital malformations such as microcephaly. In any case, more scientific tests are needed to establish the causal relationship between the virus and this malformation (7-10
...
This publication represents a key step forward in translating Control of the leishmaniases (WHO Technical Report Series, No. 949) into a more practical tool for health personnel directly involved in the case management of cutaneous leishmaniasis. With this manual, countries will have, for the first
...
PLoS Neglected Tropical diseases August 16, 2021 https://doi.org/10.1371/journal.pntd.0009697
Chagas disease, also known as American trypanosomiasis, is a neglected tropical disease transmitted by triatomine insects, first identified in 1909. Chagas disease affects approximately 6–7 million peop
...
Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493
.Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different molecular mech
...
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t
...
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 117: e200460, 2022
Integrating the multiple dimensions of the problem into a coherent approach adapted to field realities and needs represents an immense challenge, but the payoff is more effective and sustainable experiences, with higher social awareness
...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita
...
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t
...
Este manual se ha elaborado en el marco de la Iniciativa Global de la Organización Mundial de la Salud (OMS) para el Cáncer Infantil, CureAll Americas, con el propósito de mejorar la situación de los niños, niñas y adolescentes con cáncer en todo el mundo, para que puedan tener las mejores po
...
Mali national action plan on antimicrobial resistance: review of progress in the human health sector
This policy brief aims to provide a review of the current progress on implementing the Mali national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing act
...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f
...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines
...
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open-
...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines
...
A System of Health Accounts 2011: Revised Edition provides an updated and systematic description of the financial flows related to the consumption of health care goods and services. As demands for information increase and more countries implement and institutionalise health accounts according to the
...
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog
...
In 2014, the World Heart Federation (WHF) launched
an initiative to develop a series of Roadmaps [1e6]. Their
aim is to identify potential roadblocks on the pathway to
effective prevention, detection, and management of cardiovascular disease (CVD), along with evidence-based
solutions to overcome
...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr
...
In 2012, all Member States of the World Health Organization (WHO) endorsed a historical target to reduce premature mortality from noncommunicable diseases
(NCD). This commitment was echoed in 2015 by the United Nations Sustainable Development Goals, which included a target to reduce premature morta
...
